Care and outcomes of atrial fibrillation in potentially vulnerable populations: A 20-year perspective using real-world data

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Miss Nina Nouhravesh

Duke Clinical Research Institute, Durham (United States of America)

4 More presentations in this session

Presentation thumbnail

Prognostic implications of atrial fibrillation in young patients without overt heart disease - an early marker of future cardiomyopathy ?

Doctor P. Rasmussen (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Integrating pre- and post-ablation B-type natriuretic peptide to identify high-risk population for long-term adverse events and arrhythmic recurrence in persistent atrial fibrillation

Doctor S. Hashimoto (Ube, JP)

Abstract Slides Video

Presentation thumbnail

Tachycardiomyopathy is associated with metabolic changes that predict LVEF recovery - results from the EMPATHY study

Doctor D. Heinzmann (Tuebingen, DE)

Abstract Slides Video

Presentation thumbnail

ECG changes predict new-onset heart failure in patients with atrial fibrillation.

Doctor C. Binding (Copenhagen, DK)

Abstract Slides Video

Access the full session

Session thumbnail

Atrial fibrillation and heart failure: a deadly combination

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Temporal trends in initiation of oral anticoagulants and stroke-free survival among elderly and very elderly patients with new onset atrial fibrillation - a 20-year perspective.

Congress Presentation

Evolving trends in stroke prevention with focus on atrial fibrillation: ethnic and sex differences

Congress Presentation

Predicting atrial fibrillation from ECG characteristics

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources